A phase 2 study evaluated the efficacy and safety of adding pembrolizumab to trimodal therapy as a bladder-sparing approach for muscle-invasive bladder cancer (MIBC).
The results suggest the drug boasts similar safety and efficacy in non-small cell lung cancer compared with the field’s ...
Saturday's Oaklawn Handicap in Arkansas shapes up as the race of the year, with Sovereignty, Journalism and White Abarrio set ...
UFC 327 had all the ingredients needed to make an all-time great fight card.
Revised trial procedures add intensified hematologic and cardiac monitoring to mitigate toxicities consistent with dual ...
Clinically meaningful improvements in xerostomia symptoms measured by PRO Xerostomia Questionnaire (XQ) maintained out to 3 years post treatment with AAV-hAQP1 for both bilateral and unilateral ...
The parents of students who were sexually assaulted in school are pushing Illinois lawmakers to support a bill to mandate a ...
A phase 2 study suggests that immunotherapy plus radiation could spare some patients with advanced endometrial cancer from chemotherapy.
Paclitaxel remains first-line for cutaneous angiosarcoma, but absence of validated second-line therapy creates a major unmet ...
Trastuzumab pamirtecan, a HER2-targeted antibody-drug conjugate, achieved ‘exceptional’ antitumor responses in patients with recurrent endometrial cancer, especially those with HER2 IHC 3+ tumors.
Emergency crews responded to a commercial vehicle crash Thursday afternoon on Winona Grade Road near Kooskia.Kooskia ...
Talisker Resources Ltd. ('Talisker” or the 'Company”) (TSX: TSK, OTCQB: TSKFF) is pleased to report the development on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results